KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV)
CUSIP: 483497103
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 50,580,036
- Total 13F shares
- 12,995,790
- Share change
- +463,253
- Total reported value
- $256,399,000
- Price per share
- $19.75
- Number of holders
- 56
- Value change
- +$7,695,219
- Number of buys
- 31
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 483497103?
CUSIP 483497103 identifies KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 483497103:
Top shareholders of KALV - KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SV Health Investors, LLC |
13F
|
Company |
5.1%
|
2,579,490
|
$57,033,000 | — | 30 Sep 2018 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
2.8%
|
1,441,070
|
$31,862,000 | — | 30 Sep 2018 | |
| Vivo Capital, LLC |
13F
|
Company |
2.7%
|
1,359,149
|
$30,051,000 | — | 30 Sep 2018 | |
| VHCP Management III, LLC |
13F
|
Company |
2.5%
|
1,284,931
|
$28,410,000 | — | 30 Sep 2018 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
900,000
|
$19,899,000 | — | 30 Sep 2018 | |
| VHCP Management II, LLC |
13F
|
Company |
1.5%
|
759,181
|
$16,785,000 | — | 30 Sep 2018 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.3%
|
650,000
|
$14,372,000 | — | 30 Sep 2018 | |
| BVF INC/IL |
13F
|
Company |
1.2%
|
609,014
|
$13,465,000 | — | 30 Sep 2018 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
0.77%
|
388,766
|
$8,596,000 | — | 30 Sep 2018 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.6%
|
305,187
|
$6,748,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.59%
|
296,581
|
$6,558,000 | — | 30 Sep 2018 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.64%
|
322,436
|
$5,467,000 | — | 30 Sep 2018 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.44%
|
225,000
|
$4,975,000 | — | 30 Sep 2018 | |
| Boxer Capital, LLC |
13F
|
Company |
0.4%
|
200,000
|
$4,422,000 | — | 30 Sep 2018 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.4%
|
200,000
|
$4,422,000 | — | 30 Sep 2018 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.3%
|
150,000
|
$3,317,000 | — | 30 Sep 2018 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.27%
|
138,100
|
$3,053,000 | — | 30 Sep 2018 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.25%
|
128,844
|
$2,849,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
117,349
|
$2,595,000 | — | 30 Sep 2018 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.13%
|
67,460
|
$1,492,000 | — | 30 Sep 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
64,245
|
$1,419,000 | — | 30 Sep 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
52,041
|
$1,151,000 | — | 30 Sep 2018 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.08%
|
41,896
|
$926,000 | — | 30 Sep 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
41,000
|
$907,000 | — | 30 Sep 2018 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.08%
|
40,000
|
$884,000 | — | 30 Sep 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
30,694
|
$678,000 | — | 30 Sep 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
27,068
|
$598,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
19,309
|
$427,000 | — | 30 Sep 2018 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.04%
|
17,725
|
$392,000 | — | 30 Sep 2018 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.03%
|
17,551
|
$388,000 | — | 30 Sep 2018 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.03%
|
16,000
|
$354,000 | — | 30 Sep 2018 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.03%
|
12,740
|
$282,000 | — | 30 Sep 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
12,383
|
$274,000 | — | 30 Sep 2018 | |
| Spark Investment Management LLC |
13F
|
Company |
0.02%
|
12,328
|
$272,000 | — | 30 Sep 2018 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
9,755
|
$216,000 | — | 30 Sep 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
8,091
|
$179,000 | — | 30 Sep 2018 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,612
|
$124,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,202
|
$93,000 | — | 30 Sep 2018 | |
| FIRST QUADRANT LLC/CA |
13F
|
Company |
0.01%
|
3,054
|
$68,000 | — | 30 Sep 2018 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,742
|
$39,000 | — | 30 Sep 2018 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
656
|
$15,000 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
660
|
$14,000 | — | 30 Sep 2018 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
245
|
$5,000 | — | 30 Sep 2018 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
148
|
$3,000 | — | 30 Sep 2018 | |
| Valeo Financial Advisors, LLC |
13F
|
Company |
0%
|
142
|
$3,000 | — | 30 Sep 2018 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
71
|
$2,000 | — | 30 Sep 2018 | |
| Advisor Group, Inc. |
13F
|
Company |
0%
|
50
|
$1,000 | — | 30 Sep 2018 |
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q4 2018
As of 31 Dec 2018,
KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,995,790 shares.
The largest 10 holders included
SV Health Investors, LLC, RA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, VHCP Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, VHCP Management II, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ADAGE CAPITAL PARTNERS GP, L.L.C., Ghost Tree Capital, LLC, and INTERWEST VENTURE MANAGEMENT CO.
This page lists
56
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
46
Q4 2018 holders
56
Holder diff
10
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.